It's hard to pinpoint which hair-loss medications or treatments are most effective, but it's likely that the best results come from using a combination of methods
But for a large number of patients, the medications fall short, fail entirely, or come with side effects that make long-term use impossible
This letter in a narrow respect validates, at least anecdodately, the core argument firms like Novo Nordisk and Eli Lilly are making: that compounded versions of their drugs, produced outside a more robust CGMP framework, carry real and documented patient safety risks
While the FDAs Food, Drug, and Cosmetic Act allows it to turn a blind eye to pharmacists producing and selling non-approved compounded versions under certain circumstances, this practice has led to a billion-dollar shadow industry of compounded GLP-1 drugs
Y.ChanY
Shakeeb, Y.A